Recombinant multi-species GGTA1/GGTA1P protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GGTA1/GGTA1P protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Alpha-1,3-galactosyltransferase (GGTA1) is an enzyme present in most mammals except man, apes, and Old World monkeys. This gene is thought to encode a truncated, non-enzymatic form of the GGTA1 protein that lacks the C-terminal catalytic domain. Aberrant expression of the GGTA1 protein in man can lead to autoimmune diseases and sometimes germ cell tumors. [provided by RefSeq, May 2020]
The Alternative Names of target: 3-galactosyltransferase,GALT,GGTA,GGTA1,GGTA1P,GLYT2,Gal,Ggta,Ggta-1,Ggta1,Ggta1p,Glycoprotein alpha-galactosyltransferase 1 pseudogene,Inactive N-acetyllactosaminide alpha-1,a1/3GTP,alpha Gal,alpha3GalT

Target products collectionGo to GGTA1/GGTA1P products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0903-Ag-1/ GM-Tg-hg-IP0903-Ag-2 Human GGTA1/GGTA1P protein Human
GM-Tg-rg-IP0903-Ag-1/ GM-Tg-rg-IP0903-Ag-2 Rat GGTA1/GGTA1P protein Rat
GM-Tg-mg-IP0903-Ag-1/ GM-Tg-mg-IP0903-Ag-2 Mouse GGTA1/GGTA1P protein Mouse
GM-Tg-cynog-IP0903-Ag-1/ GM-Tg-cynog-IP0903-Ag-2 Cynomolgus/Rhesus macaque GGTA1/GGTA1P protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0903-Ag-1/ GM-Tg-felg-IP0903-Ag-2 Feline GGTA1/GGTA1P protein Feline
GM-Tg-cang-IP0903-Ag-1/ GM-Tg-cang-IP0903-Ag-2 Canine GGTA1/GGTA1P protein Canine
GM-Tg-bovg-IP0903-Ag-1/ GM-Tg-bovg-IP0903-Ag-2 Bovine GGTA1/GGTA1P protein Bovine
GM-Tg-equg-IP0903-Ag-1/ GM-Tg-equg-IP0903-Ag-2 Equine GGTA1/GGTA1P protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0903-Ag-1/ GM-Tg-hg-IP0903-Ag-2; GM-Tg-rg-IP0903-Ag-1/ GM-Tg-rg-IP0903-Ag-2;
GM-Tg-mg-IP0903-Ag-1/ GM-Tg-mg-IP0903-Ag-2; GM-Tg-cynog-IP0903-Ag-1/ GM-Tg-cynog-IP0903-Ag-2;
GM-Tg-felg-IP0903-Ag-1/ GM-Tg-felg-IP0903-Ag-2; GM-Tg-cang-IP0903-Ag-1/ GM-Tg-cang-IP0903-Ag-2;
GM-Tg-bovg-IP0903-Ag-1/ GM-Tg-bovg-IP0903-Ag-2; GM-Tg-equg-IP0903-Ag-1/ GM-Tg-equg-IP0903-Ag-2
Products Name GGTA1/GGTA1P protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name GGTA1/GGTA1P
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GGTA1/GGTA1P protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.